HIMS Lecture 18 March 2026
PhD presentations by Leontii Shtokolenko and Ashique Lal. Invited speaker: Prof. Paul Ferguson (Chair by Special Appointment - Separation of Biomacromolecules, with an emphasis on Sustainable Analytical Science)
Event details from: HIMS Lecture 18 March 2026
- Date
- 18 March 2026
- Time
- 14:00 – 16:00
Venue
SP C3.161
Host
Andrea Gargano
PhD lectures
14:00 - Lecture 1
Leontii Shtokolenko (Dubbeldam group)
Title: Developing methods for high-throughput computational screening of microporous materials
14:15 - Lecture 2
Ashique Lal (Bolhuis group)
Title: Active learning of machine-learned interatomic potentials using transition path sampling
Invited speaker
Prof. Paul Ferguson (Chair by Special Appointment – Separation of Biomacromolecules, with an emphasis on Sustainable Analytical Science)
Title: Sustainability considerations in the development of new modality chromatographic methods
Abstract
In recent years there has been an increasing focus on the sustainability and/or ‘greenness’ of processes within the pharmaceutical industry. While this has predominantly focussed on process chemistry and manufacturing scale-up of drugs, latterly formulation activities and analytical methods have come under scrutiny.
There have been several publications referring to improving chromatographic method greenness or developing methods in a sustainable manner for small-molecules (e.g. solid-oral dosage form pharmaceuticals), but to date, there has been little discussion on how these approaches may be utilised for larger new modality therapeutics e.g. biomolecules or complex delivery systems.
In this presentation we will initiate this discussion with a focus on method development for peptide and synthetic oligonucleotides (ASO, siRNA). We will demonstrate and exemplify opportunities to implement method and process enhancements that can decrease the environmental impact of methods from both a waste and carbon dioxide footprint perspective.
Bio
Paul Ferguson joined HIMS in 2025 as professor by special appointment in the position titled ‘Separation of Biomacromolecules, with an Emphasis on Sustainable Analytical Science’. The focus of this role is to develop next generation separation science for new modality compounds (particularly peptides and oligonucleotides) which are greener and more sustainable than current contemporary standards. Areas within scope for research are many forms of separation science (which is the highest polluter of all the analytical sciences), spectroscopy and spectrometry. Another focus area is the use of in-silico approaches to streamline method development and data reporting. This position aligns very closely with his role at AstraZeneca where he is a Principal Scientist in Global Product Development (Macclesfield, UK). He has worked in the pharmaceutical industry for over 25 years with many of his roles focusing on separation science and many different molecule types. He currently works with several HIMS colleagues (Dr Bob Pirok, Dr Andrea Gargano and Dr Saer Samanipour) on the NWO Key Technologies funded InnovATOR project.
